Page last updated: 2024-12-05

n,2,6-trichloro-4-benzoquinone imine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,2,6-trichloro-4-benzoquinone imine: universal thin-layer chromatographic visualization reagent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7556
CHEMBL ID3276931
SCHEMBL ID478999
MeSH IDM0055789

Synonyms (69)

Synonym
2,6-dichloroquinone-4-chloroimide
gibbs reagent
n-2,6-trichloro-p-benzoquinonimine
n-2,6-trichloro-p-benzoquinone imine
2,6-dichlorobenzoquinone chloroimide
2, 2,6-dichloro-4-(chloroimino)-
2,6-dichloro-4-n-chloroquinonimine
2,6-dichloroquinone chloroimide
p-benzoquinone imine,2,6-trichloro-
2,6-dichloroquinonechloroimine
2, 4-chloroimino-2,6-dichloro-
n,6-trichlorobenzoquinone imine
wln: l6v dyj bg dung fg
n,6-trichloro-p-benzoquinonimine
2,6-dichloroquinone-4-chloroimine
101-38-2
nsc6293
nsc-6293
2,6-dichloro-4-(chloroimino)-2,5-cyclohexadien-1-one
einecs 202-937-2
nsc 6293
n,2,6-trichloro-4-benzoquinone imine
n,2,6-trichlorobenzoquinone imine
n,2,6-trichloro-p-benzoquinonimine
4-chloroimino-2,6-dichloro-2,5-cyclohexadiene-1-one
n,2,6-trichloro-p-benzoquinone imine
ai3-52333
brn 2364249
2,5-cyclohexadien-1-one, 4-chloroimino-2,6-dichloro-
2,6-dichloro-4-(chloroimino)cyclohexa-2,5-dienone
p-benzoquinone imine, n,2,6-trichloro-
2,5-cyclohexadien-1-one, 2,6-dichloro-4-(chloroimino)-
2,6-dichloro-1,4-quinone-4-chlorimide
2,6-dichloro-4-chloroiminocyclohexa-2,5-dien-1-one
inchi=1/c6h2cl3no/c7-4-1-3(10-9)2-5(8)6(4)11/h1-2h
yhumthwqgwpjoq-uhfffaoysa-
n,2,6-trichloro-p-benzoquinone monoimine
T0397
n,2,6-trichloroquinoneimine
A800380
3-07-00-03377 (beilstein handbook reference)
unii-y19a13rzo0
y19a13rzo0 ,
FT-0610633
AKOS015901257
gibbs reagent [mi]
n,2,6-trichloro-p-quinoneimine
CHEMBL3276931
DTXSID2059229
SCHEMBL478999
J-610063
2,6-dichloroquinone-4-chlorimide
YHUMTHWQGWPJOQ-UHFFFAOYSA-N
gibbs' reagent
2,6-dichloro-4-(chloroimino)-2,5-cyclohexadien-1-one #
2,6-dichloro-p-benzoquinone-4-chlorimine
W-108918
mfcd00001611
2,6-dichloroquinone-4-chloroimide, for spectrophotometric det. of vitamin b6, >=99.0%
2,6-dichloroquinone-4-chloroimide, 99.0%
(s)-benzyl?1-chloropropan-2-ylcarbamate
Q209277
FS-4501
D88188
2,6-dichloro-4-(chloroimino)cyclohexa-2,5-dien-1-one
SY048612
HY-W105135
CS-0157777
PD197261

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The suggested procedures could be used for the determination of mequitazine, both in pure and dosage forms, as well as in the presence of its degradate."( Stability indicating methods for assay of mequitazine in presence of its degradate.
Badawey, AM; El Khateeb, SZ; El-Ragehy, NA, 2002
)
0.31
" The proposed methods were validated according to ICH guidelines and were successfully applied for the determination of VN and NF in their tablet dosage forms."( Application of π acceptors to the spectrophotometric and spectrofluorimetric determination of vincamine and naftidrofuryl oxalate in their pharmaceutical preparations.
Badr El-Dien, MM; Elbrashy, AM; Ibrahim, FA; Nasr, JJM, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1148231Half life of the compound in water at pH 7 at 25 degC by spectrophotometry1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Nitrogen analogues of 1,4-benzoquinones. Activities against the ascitic sarcoma 180 of mice.
AID1148235Antitumor activity against mouse Sarcoma 180 cells allografted in Swiss mouse assessed as survival at 10 mg/kg, ip three doses were given at 24 hrs interval starting 24 hrs after allograft injection measured after 5 days1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Nitrogen analogues of 1,4-benzoquinones. Activities against the ascitic sarcoma 180 of mice.
AID1148260Antitumor activity against mouse Sarcoma 180 cells allografted in Swiss mouse assessed as cure at 10 mg/kg, ip three doses were given at 24 hrs interval starting 24 hrs after allograft injection measured after 60 days1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Nitrogen analogues of 1,4-benzoquinones. Activities against the ascitic sarcoma 180 of mice.
AID1148285Antitumor activity against mouse Sarcoma 180 cells allografted in Swiss mouse at 10 mg/kg, ip three doses were given at 24 hrs interval starting 24 hrs after allograft injection relative to control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Nitrogen analogues of 1,4-benzoquinones. Activities against the ascitic sarcoma 180 of mice.
AID1148270Antitumor activity against mouse Sarcoma 180 cells allografted in Swiss mouse assessed as survival time at 10 mg/kg, ip three doses were given at 24 hrs interval starting 24 hrs after allograft injection relative to control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Nitrogen analogues of 1,4-benzoquinones. Activities against the ascitic sarcoma 180 of mice.
AID1148228Antitumor activity against mouse Sarcoma 180 cells allografted in Swiss mouse assessed as weight gain at 10 mg/kg, ip three doses were given at 24 hrs interval starting 24 hrs after allograft injection measured after 3 days relative to control1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Nitrogen analogues of 1,4-benzoquinones. Activities against the ascitic sarcoma 180 of mice.
AID1148298Redox potential of the compound in octanol-water solution1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Nitrogen analogues of 1,4-benzoquinones. Activities against the ascitic sarcoma 180 of mice.
AID1148232Acute toxicity in single ip dosed Swiss mouse assessed as death up to 5 days1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Nitrogen analogues of 1,4-benzoquinones. Activities against the ascitic sarcoma 180 of mice.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (41.18)18.7374
1990's2 (11.76)18.2507
2000's6 (35.29)29.6817
2010's2 (11.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.37 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]